FIS › analyze
FIS · Analyze
A portfolio-specific passage was removed from the public build.
⚠️ Read This First — The Headline P/E Is Fiction
Every screener shows FIS at 6.58x trailing earnings. That number is wrong, and the error is 3x.
The tripwire fires immediately: net margin 28% against operating margin 21%. Net margin
cannot exceed operating margin from operations — interest and tax only subtract. Per
Knowledge/Playbook/pattern-net-margin-above-operating-margin-is-a-tripwire, the excess
came from below the operating line, and it did.
Q1 2026 income statement, the whole story in one row:
| Line | Q1 2026 |
|---|---|
| Pretax income | $259M |
| Earnings from equity interest, net of tax | +$2,214M |
| Net income | $2,366M |
| Diluted EPS | $4.58 |
That $2,214M is the gain on selling the remaining 45% Worldpay stake to Global Payments, which closed 9 January 2026. It is a one-time disposal gain. It is not coming back.
TTM reconstruction (diluted EPS, verified against the company's own prints):
| Quarter | Reported EPS | Equity-interest item | Core EPS |
|---|---|---|---|
| Q3 2025 | $0.50 | −$23M | $0.50 |
| Q4 2025 | $0.98 | +$166M | ~$0.66 |
| Q1 2026 | $4.58 | +$2,214M | $0.29 |
| Q2 2026 | $0.45 | — | $0.45 |
| TTM | $6.51 ✓ | ≈$2.22 |
The TTM total reproduces Yahoo's $6.51 exactly, which confirms the statement data is sound and only the derived ratio misleads.
| Basis | TTM EPS | P/E at $42.81 |
|---|---|---|
| Headline GAAP (every screener) | $6.51 | 6.6x |
| Core, ex-Worldpay disposal | $2.22 | 19.3x |
| Company's own FY26 adjusted guide | $6.15–6.24 | 6.9x |
The forward P/E of 6.38 is also not what it appears. It implies EPS of $6.71 — neither
GAAP (FY26 GAAP EPS will land near $1.80–2.00) nor the company's FY26 adjusted guide of
$6.15–6.24. It is most likely FY2027 consensus adjusted EPS.
Per pitfall-vendor-forward-eps-is-the-wrong-fiscal-year, the direction of that error is
always toward cheap. This report uses the company's own $6.20 midpoint.
Every valuation number below is built on core earnings, adjusted EPS, or free cash flow. None of them use the $6.51.
Phase 1 — Fundamentals
What actually happened to this company
Three events define the entire financial record and make most multi-year CAGRs unusable:
- 2019 — FIS bought Worldpay for $43B.
- 2022–23 — wrote off roughly $24B of that in goodwill impairments. Net losses of −$16.75B (2022) and −$6.66B (2023).
- 2024–26 — sold 55% of Worldpay to GTCR (Jan 2024), then the remaining 45% to Global Payments (Jan 2026), and used the proceeds plus $7.7B of new debt to buy Global Payments' Issuer Solutions (legacy TSYS) for $13.5B EV.
Per pitfall-divested-segment-corrupts-multiyear-cagr, no clean 5–8yr CAGR is computable
for FIS. The fin.py output reports "FCF CAGR 42.9% (3y)" and "Revenue CAGR 3.2% (3y)" —
both cross the Worldpay deconsolidation boundary and neither means anything. Flagging that is
the finding, not a gap. The comparable basis starts FY2024.
Income statement — reported
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026E (guide) | |
|---|---|---|---|---|---|
| Revenue | $9.72B | $9.83B | $10.13B | $10.68B | $13.63–13.70B |
| Gross profit | $3.46B | $3.66B | $3.80B | $3.94B | — |
| Operating income | $1.28B | $1.56B | $1.76B | $1.76B | — |
| Net income | −$16.75B | −$6.66B | $1.45B | $0.38B | — |
| Diluted EPS | −$27.68 | −$11.26 | $2.61 | $0.73 | ~$1.80–2.00 GAAP |
| Adjusted EPS | — | — | — | ~$5.75 | $6.15–6.24 |
| Diluted shares | 604M | 591M | 555M | 525M | ~517M |
The +29% FY26 revenue growth is entirely acquired. Pro forma organic growth in Q2 2026 was 5.3%. That is the real number and it should be used everywhere the headline appears.
Free cash flow — the only clean lens
| FY2023 | FY2024 | FY2025 | FY2026E | |
|---|---|---|---|---|
| Operating cash flow | $4.33B | $2.07B | $2.82B | — |
| Capex | −$0.78B | −$0.82B | −$0.99B | — |
| Free cash flow | $3.56B* | $1.25B | $1.83B | $2.15–2.25B |
| FCF/share | — | $2.25 | $3.48 | ~$4.26 |
| Growth | — | — | +46% | +20% |
* FY2023 includes consolidated Worldpay — not comparable.
On the post-Worldpay basis FCF has compounded ~33%/yr for two years and the FY26 guide was RAISED at Q2 even while EPS guidance was cut. That is the single most encouraging fact in the print: cash is arriving faster than the P&L implies, and cash is what services the debt.
Equity FCF yield at $22.08B market cap: ~9.9%. On EV: 5.2%.
Capital allocation — FY2022–2025 cumulative
| Use | Amount | Comment |
|---|---|---|
| Buybacks | $7.93B | Retired 15% of shares — the real per-share tailwind |
| Acquisitions | $5.85B | Plus $13.5B more in Jan 2026 |
| Dividends | $4.02B | Includes a 31% cut in 2024 |
| Capex | $3.59B | ~9% of revenue — respectable reinvestment |
| Total returned + invested | $21.4B | |
| FCF generated over the same period | $7.27B |
They deployed roughly 3x the cash they generated. The gap was funded by Worldpay disposal proceeds and debt. This is not a company that has been living within its means; it is a company recycling the wreckage of one deal into the next one.
Balance sheet — the leverage step-change
| FY2025 | Q1 2026 | Δ | |
|---|---|---|---|
| Total assets | $33.49B | $43.48B | +$10.0B |
| Total debt | $13.33B | $21.15B | +$7.8B |
| Net debt | $12.48B | $20.30B | +$7.8B |
| Debt / Assets | 39.8% | 48.6% | ⚠️ |
| Goodwill | $17.76B | $24.59B | |
| Goodwill + intangibles | $21.60B | $34.26B | 79% of assets |
| Stockholders' equity | $13.90B | $15.98B | |
| Tangible book value | −$7.70B | −$18.28B | ⚠️ |
| Retained earnings | −$22.72B | −$20.58B | The Worldpay hole, on the page |
| Current ratio | 0.54 | 0.59 | Normal for a processor with settlement float |
| Commercial paper | $2.73B | $4.15B | Short-term funding reliance |
Tangible book per share is −$35.35. Paid-in capital is $47.4B; retained earnings are −$20.6B. Shareholders contributed $47B and $21B of it is gone. P/B of 1.39 is a pure goodwill artifact and Graham's formula is unusable here — both of its inputs (EPS $6.51, BVPS $30.90) are contaminated. It would print $67.28. Discard it. See the Valuation section.
Leverage: 3.6x gross on management's adjusted-EBITDA basis (FY26 adj EBITDA ≈ $5.6B implied by 41.5% Q2 margin on $13.65B revenue — this reconciles, so the 3.6x is honest). Target 2.8x. Interest expense ran $197M in Q1 2026 vs $112M in Q4 2025; annualising to ~$800M. Coverage on adjusted EBITDA ~7x; on GAAP operating income ~2.6x.
🚩 The deleveraging arithmetic does not close on cash flow alone
To reach 2.8x from 3.6x on ~$5.6B EBITDA requires cutting net debt from $20.3B to ~$15.7B — $4.6B of paydown.
Available: FCF $2.2B − dividends $0.91B = $1.29B/yr. Even crediting EBITDA growth (5% organic + $150M of Issuer Solutions synergies by 2028 → maybe $6.2B, needing $17.4B of net debt = $2.9B of paydown), that is 2.3 years minimum, and 3.6 years at flat EBITDA.
Management says end-2027. The plan therefore depends on selling Capital Markets assets — which is exactly what they announced they are exploring. That connection is the most important thing in this report and it is not in the press release.
Shares outstanding — the tailwind just switched off
604M → 591M → 583M → 531M → 514M. A −4.6%/yr reduction that did meaningful work on per-share value.
Buybacks are paused until leverage reaches 2.8x, targeted end-2027. Q1 2026 net common stock issuance was −$67M, essentially tax withholding. Against $1.43B in 2025 and $4.04B in 2024. For roughly two years there is no per-share tailwind from repurchase. Every dollar of upside goes to the lenders first.
Fundamentals scorecard
| Metric | Reading | Grade |
|---|---|---|
| FCF trajectory (post-Worldpay basis) | +46%, +20%, guide raised | ✅ Strong |
| FCF 5–8yr CAGR | Not computable — divestiture breaks the series | ⚠️ Flagged |
| Organic revenue growth | 5.3% pro forma | 🟡 Adequate |
| Debt / Assets | 48.6%, up 880bp in one quarter | 🔴 Elevated |
| Tangible book | −$18.28B | 🔴 Negative |
| Share count | −4.6%/yr, now paused ~2 years | 🟡 Was good, is stalled |
| Capital allocation record | $24B written off; 3x FCF deployed | 🔴 Poor |
| Dividend coverage (FCF) | 41% | ✅ Covered |
| Data quality | TTM EPS 66% non-operating; CAGRs corrupted | 🔴 Two traps |
Phase 2a — Moat
Quantitative base
| FY2024 | FY2025 | |
|---|---|---|
| Gross margin | 37.6% | 36.9% ↓ |
| Operating margin | 17.4% | 16.5% ↓ |
| Adjusted EBITDA margin | 34.0% | 33.9% → (41.5% in Q2 2026 post-deal) |
| ROIC | 3.7% | 4.9% |
| ROE | 8.3% | 2.6% |
(ROIC/ROE per roic.ai, annual.)
ROIC of 3.7–4.9% against a cost of capital near 8–9% is the entire moat story compressed into one number. FIS does not earn its cost of capital on the capital it has invested.
The bull's rebuttal is legitimate and should be stated: that low ROIC is measured against $37B of invested capital that is 79% goodwill and intangibles. On tangible operating assets the returns are excellent — the Banking segment ran a 45.8% adjusted EBITDA margin in Q2 2026, up 179bp. The franchise throws off cash beautifully.
Both things are true, and the reconciliation is the investment case: the underlying franchise is high-return; the corporate entity that owns it is not, because management keeps converting the franchise's cash into goodwill. For a shareholder, the second number is the one that determines the return.
The moat itself — real, and decaying by attrition
Source: switching costs, and they are among the highest in enterprise software. A bank's core system is a multi-year, career-ending migration. Contracts run 5–7 years, retention is in the high 90s, recurring revenue is ~80%+ of the mix, and Q2 recurring growth was 5.0% in Banking and 5.3% in Capital Markets.
Source: efficient scale. Five vendors — Temenos, Oracle, Infosys, FIS, Fiserv — hold roughly 55% of core banking. New entrants cannot buy their way into an installed base.
Adversarial stress-test — "you are a well-funded rival, take this market."
What you cannot do: rip out FIS's existing cores. Not in five years, not with unlimited capital. The switching cost is borne by the customer, not you, and no regional bank CIO volunteers for that project.
What you absolutely can do: take every new charter, every digital-first bank, every greenfield deployment, and — most damaging — every modernization budget. Thought Machine, Mambu and 10x Banking (past 10M live accounts) have proven cloud-native cores work at real banks. FIS's switching-cost moat only pays if clients modernize through FIS rather than using the modernization decision as the moment to leave.
That is a moat that erodes by attrition rather than by assault — and 5.3% organic growth with a 3% Capital Markets segment is precisely what slow attrition looks like on an income statement.
Revenue-stream map
| Stream | Q2 2026 revenue | Growth | Durability |
|---|---|---|---|
| Banking Solutions (incl. Total Issuing) | $2,483M (+44% reported, +6.1% pro forma) | 45.8% EBITDA margin, +179bp | ✅ The moat. High switching costs, ~80% recurring |
| Capital Markets | $810M (+3.2% adj) | 51.9% EBITDA margin, −32bp | ⚠️ Highest margin, lowest growth, now being shopped |
| Issuer Solutions (TSYS) | folded into Banking | $150M+ synergies by 2028 | 🟡 Legacy card-issuer processing GPN chose to sell |
Note what FIS just bought. Issuer Solutions is the legacy TSYS card-issuing platform. Global Payments wanted it off their books badly enough to trade it for Worldpay. FIS levered up $7.7B to take it. It may well be a good fit — issuer processing is genuinely adjacent to bank cores and the margins are accretive — but the seller's motivation deserves to be on the record.
Disruption forecast, 5–10 years
- Cloud-native cores — the live threat, and it is commercial rather than theoretical. Takes new formation and modernization spend, not the installed base.
- AI agents — FIS is shipping AI and digital-asset features, but management stated AI revenue is not in the 2026 guidance and expects it to become "meaningful in 2027." That is optionality, not a moat, and it should be valued at zero today.
- Stablecoins / bank-issued digital money — cuts both ways. Fiserv is launching a bank stablecoin; FIS is building digital-asset rails. Rails incumbents usually get to be the plumbing for the new thing. Not a near-term threat.
- Vendor consolidation by banks — the more real medium-term risk: as banks consolidate, each merger is a re-bid. UBS/Credit Suisse cost FIS Capital Markets revenue and is named in the guidance cut.
Evergreen assessment
Banks will always need cores. FIS specifically is not evergreen. It is a rentier on an installed base it must keep re-buying — $5.85B of acquisitions in four years and $13.5B more in January. The franchise outlives any given owner; the shareholder's claim on it does not compound unless management stops paying full price for growth.
Evergreen rating: 4/10. Durable revenue, undurable per-share value creation.
Moat defense — what management is doing
Deleveraging to 2.8x, pausing buybacks and tuck-in M&A, $150M+ of Issuer Solutions synergies by 2028, cost management delivering +113bp of consolidated adjusted EBITDA margin in Q2, and a portfolio review of Capital Markets. The risk/reward on that effort is fair — it is the right list. The concern is that the same team wrote the previous list.
Phase 2b — Valuation
Model applicability
| Model | Verdict | Why |
|---|---|---|
| Graham IV | ❌ DISCARD | Would print $67.28 from √(22.5 × 6.51 × 30.90). EPS is 66% Worldpay disposal gain; BVPS is 100%+ goodwill against −$35.35 tangible book. Both inputs broken. On core EPS $2.22 and negative tangible book the formula is undefined. Reporting the $67 would be pitfall-gate-cleared-by-adjective-not-arithmetic in action. |
| DYT | ❌ DISCARD, then reset | See below — three of four guard questions fail. |
| DDM (Gordon) | ✅ Applicable | Covered dividend, stable-ish grower. |
| FCF multiple | ✅ Primary | Sits above the contaminated line; the guide was raised. |
| Adjusted-EPS multiple | ✅ Secondary, haircut | Adjusted EPS excludes ~$2.5B/yr of intangible amortisation at a company whose strategy is buying intangibles. |
| Bogle | ✅ Context |
DYT, run properly
Naive: yield 4.11% vs 5yr average 2.39% → $1.76 ÷ 0.0239 = $73.64, a 72% upside call.
Now the guard from pitfall-dyt-inverts-when-price-caused-the-yield:
| Question | Answer | Pass? |
|---|---|---|
| Why did the yield rise? | Dividend $1.44 → $1.76 (+22% over 2yrs); price $72.91 → $42.81 (−41%). Mostly price. | ❌ |
| Progressive or formulaic policy? | Two consecutive raises — but the company cut the dividend 31% in 2024 ($0.52 → $0.36/qtr). Demonstrated willingness to reset. | ❌ |
| Was the band set in a boom? | The 2021–26 window includes FIS at $90–150 as a "payments compounder" on 12–18x adjusted. Bubble artifact. | ❌ |
| Does FCF cover it? | $0.91B ÷ $2.2B = 41%. Comfortably. | ✅ |
Discard the $73.64. Reset the band to the peer class FIS is becoming — a 3.6x-levered, 5%-organic-growth IT-services annuity with a covered payout. That warrants 3.5–4.5%:
DYT (reset): $1.76 ÷ 0.045 = $39 → $1.76 ÷ 0.035 = $50.
The other models
| Model | Assumptions | Output |
|---|---|---|
| FCF multiple (primary) | FY26 FCF $2.2B. 11–13x FCF for a 5% grower at 3.6x leverage with sub-WACC ROIC | $47–56 |
| — bear case | 9–10x FCF (where the market has it) | $38–43 |
| DDM (Gordon) | D₁ = $1.90, r = 10%, g = 5–6% | $38–48 |
| Adjusted-EPS multiple | FY26 adj EPS $6.20 × 7–9x (haircut from 8–10x for the amortisation add-back quality) | $43–56 |
| Bogle expected return | 4.1% yield + 7–8.5% adj EPS growth, no re-rating | ~11–13%/yr |
| — with re-rating to 9x over 3yrs | ~20%/yr | |
| — with de-rating to 5.5x | ~5%/yr |
Convergence
DYT-reset $39–50 · DDM $38–48 · FCF multiple $47–56 (bear $38–43) · adj-EPS $43–56.
Fair value: $42–54, midpoint ~$48
Price $42.81 sits at the bottom edge of fair value — not below it.
Sell-side mean target is $56.55, above my top end. Note that every covering firm cut its target on 5 August; the mean has not finished falling.
Entry zone: $36–42. At $38 the equity FCF yield is ~11.6% and the dividend yield 4.6% at 41% of FCF — a price at which the deleveraging math works even if nothing improves. Trim: 8x forward adjusted. (Set at 8x rather than 9x deliberately: the site computes the dollar level from Yahoo's forward P/E, whose implied EPS of $6.71 runs ~8% above the company's own $6.20 guide, so 8x lands near my $54 ceiling.)
Phase 3 — Sentiment & the Q2 Print
Q2 2026 (reported 4 August 2026)
| Metric | Result | vs expectation |
|---|---|---|
| Revenue | $3,377M (+29% GAAP, +5.3% pro forma) | Light |
| Adjusted EPS | $1.48 (+9%) | vs $1.47 est — thin beat |
| GAAP net earnings / EPS | $231M / $0.45 | 70% of adjusted EPS is add-backs |
| Adjusted EBITDA | ~$1.4B (+35%), margin +193bp | Good |
| Banking Solutions | $2,483M, +6.1% pro forma, 45.8% EBITDA margin (+179bp) | High end of outlook ✅ |
| Capital Markets | $810M, +3.2%, 51.9% margin (−32bp) | Miss 🔴 |
| Free cash flow | $525M — more than tripled YoY | ✅ |
The guidance cut — what actually broke
| Prior | Revised | Consensus | |
|---|---|---|---|
| FY26 revenue | — | $13.63–13.70B | $13.8B ❌ |
| FY26 adjusted EPS | — | $6.15–6.24 | $6.28 ❌ |
| FY26 free cash flow | — | $2.15–2.25B — RAISED | ✅ |
| Capital Markets growth | 5.25–5.75% | 3.0–3.5% (−225bp) | ❌ |
| Q3 adjusted EPS | — | $1.58–1.62 | $1.65 ❌ |
| Q3 revenue | — | ~$3.4B | $3.5B ❌ |
CEO Stephanie Ferris: "We are not satisfied with our performance in Capital Markets."
The composition of the miss matters more than the size. Management split it into two causes: known UBS/Credit Suisse merger attrition — priced, forgivable — and internal execution misses in professional-services conversion, which was not priced and is the damaging half. A demand problem you wait out; an execution problem you have to believe gets fixed by the people who caused it.
Read the two directions together: EPS guidance down, FCF guidance up. The business is converting to cash better than to accounting profit. For a company whose defining problem is $20.3B of net debt, that is the more relevant of the two lines — but it is also the line the market pays the least for.
Sell-side reaction — uniform, one-way
Every covering firm cut its target on 5 August:
| Firm | Rating | Target |
|---|---|---|
| UBS | Buy → Neutral ⬇ | $63 → $49 |
| Wells Fargo | Overweight | $67 → $58 |
| TD Cowen | Buy | $62 → $58 |
| KBW | Outperform | $60 → $56 |
| RBC | Outperform | $57 → $53 |
| Citigroup | Neutral | $48 → $45 |
| Barclays | Equal-Weight | $44 → $43 |
| Truist (24 Jul) | Hold | $45 → $43 |
Mean target $56.55. JP Morgan was at $80 in February. Not one firm raised. When the bearish targets ($43–45) sit at the current price and the bullish ones ($53–58) sit at my fair-value ceiling, the sell-side range and my model agree more than usual.
Insider activity
A portfolio-specific passage was removed from the public build.
One genuine signal: the CEO put $1M of her own money in at $50. No cluster buying since (contrast FISV, where six insiders bought together after its CEO news). No insider has bought since the guidance cut.
Positioning
Institutional ownership ~100% of float; short interest 4.0% — not a crowded short. The selling is long-only capitulation, not a squeeze setup.
Phase 4 — Debate Round
Tension 1 — Fundamentals ("FCF is compounding 20–33% and guidance was raised") vs Moat ("ROIC is 4.9%, below cost of capital").
Fundamentals' rebuttal: ROIC is a backward-looking indictment of the 2019 Worldpay deal sitting in the denominator forever. The FCF is arriving now, in cash, and it is accelerating.
Moat's counter, and it holds: the low ROIC is not just historical. They levered up $7.7B in January 2026 to buy an asset the seller wanted rid of. That is a fresh entry to the same denominator, made by the same team, this year. The 2019 deal is history; the pattern is not.
Resolution — Moat wins on weight, Fundamentals wins on timing. The correct reading is that FIS generates real cash and reliably converts it into something worth less. That combination is worth a multiple, and a low one. It is not worth zero, which is roughly what 6.9x adjusted implies.
Tension 2 — Valuation ("$42–54, price is inside the range") vs Sentiment ("mean target $56.55, seven of nine firms above $49").
Valuation's position: the sell-side is anchored to adjusted EPS and has not marked the paused buyback, the 48.6% debt/assets, or the fact that the deleveraging plan needs an asset sale to close. Every one of those targets was just cut, and the direction is one-way.
Sentiment concedes. The targets are trailing indicators here.
Tension 3 — the one that decides the verdict. Is FIS the same trade as FISV, which is already held?
| FIS | FISV (held @ ~$59.87) | |
|---|---|---|
| Price | $42.81 | $54.11 |
| Forward P/E (Yahoo) | 6.38x | 6.10x |
| 52wk high → now | −41% | −61% ($140.42 → $54.11) |
| Trigger | Q2'26 guidance cut | Oct 2025 guidance cut (−44% in one day) |
| Moat | Core banking, high switching costs | Core banking, 42% of US banks |
| Dividend | 4.11%, covered at 41% of FCF | None |
| Leverage | 3.6x, buyback paused to 2027 | Lower; buyback active; insiders bought in cluster |
| Sell-side mean target | $56.55 | $66.62 |
| Live verdict | WATCH 5.0 (this report) | HOLD, prior conviction 5.5–7 |
A portfolio-specific passage was removed from the public build.
The one thing FIS adds that FISV does not is a 4.11% covered dividend, which fits the stated growth→income transition. That is a genuine argument, and it is why the verdict is WATCH rather than AVOID.
Verdict
WATCH — Conviction 5.0 / 10
Answer the two framework questions honestly.
Is this a good business? Partly. The core-banking franchise is genuinely moated — highest-in-software switching costs, ~80% recurring revenue, 45.8% Banking EBITDA margins, +5.0% recurring growth. But the company earns 4.9% on invested capital because management converts that franchise's cash into goodwill at full price, and it did so again seven months ago. Capital Markets — a quarter of revenue at the highest margin in the house — grows 3% and is being shopped.
Has the market priced it in? Mostly, yes. At 6.9x guided adjusted EPS and a ~10% equity FCF yield the market is pricing structural decline. It is doing so with cause: guidance cut, execution miss admitted, buyback off for two years, 48.6% debt/assets, negative tangible book.
So this is not "great company, cheap." It is the middle box — a good franchise owned by a mediocre capital allocator, at a genuinely low price — where the return depends entirely on whether the deleveraging executes.
What holds me back is not the price. It is that there is no per-share tailwind for two years. Buybacks paused until 2027. Dividend growing ~10% off a base that was cut 31% in 2024. Organic growth 5%. Every dollar above guidance goes to lenders. The bull case requires a multiple re-rating, and the catalyst for that — leverage at 2.8x — is 18+ months away with a Capital Markets divestiture of unknown price in between. At $42.81, inside fair value, you are not being paid to wait through that.
What would move me to ACCUMULATE: price at $36–40 (FCF yield ~11.5%, dividend ~4.7%), or Q3 confirming Capital Markets stabilised, or a Capital Markets sale at a credible price that visibly closes the deleveraging gap, or cluster insider buying below $42.
What would move me to AVOID: a second consecutive guidance cut · FCF guidance reduced · leverage rising rather than falling by Q4 · any dividend action other than an increase · a Capital Markets sale at a distressed multiple.
Key risks, named
- 🔴 Capital allocation. $24B written off on Worldpay; retained earnings −$20.6B; then $13.5B of fresh leverage into a business the seller was exiting. The single largest risk is that the pattern repeats.
- 🔴 The deleveraging plan does not close on organic cash flow. $1.29B/yr of free cash after dividends against $4.6B of required paydown. It needs the asset sale. If Capital Markets does not sell, or sells cheap, the 2027 buyback resumption slips and the entire re-rating thesis slips with it.
- 🟠 Execution credibility. Management conceded internal professional-services conversion misses, not just market conditions. That is the harder problem.
- 🟠 Moat decay by attrition. The installed base is safe; new formation and modernization spend is not. 5.3% organic growth is what that looks like early.
- 🟠 Interest-rate sensitivity. $4.15B of commercial paper plus $21.1B total debt. Interest expense already stepped from $112M to $197M per quarter.
- 🟡 Data traps. Two live on this name — see the top of this report. Any screen or third-party summary quoting "FIS at 6.6x earnings" is wrong by 3x.
A portfolio-specific passage was removed from the public build.
Sources
- FIS Q2 2026 Earnings Call Highlights — GuruFocus
- FIS Reports Second Quarter 2026 Results — FIS IR
- FIS Form 8-K Q2 2026 exhibit 99.1 — SEC
- FIS Form 10-Q, period ended 2026-06-30 — SEC
- Fidelity National Information stock slumps after cutting guidance — Seeking Alpha
- FIS seeks to sell parts of capital markets unit — Payments Dive
- FIS Completes Issuer Solutions Acquisition and Worldpay Divestiture — FIS
- Global Payments closes Worldpay purchase, issuer sale to FIS — American Banker
- FIS Q2 2026 Earnings: Total Issuing Solutions Lifts Revenue and Margins — TradingKey
- FIS Stock Is Down 31% in 2026 — TIKR
- Core Banking Platforms Compared 2026 — 10x Banking
- FIS Dividend History — FIS IR
- Yahoo Finance MCP (
get_stock_info, quarterly income statement / balance sheet / cash flow,get_recommendations,get_holder_info,get_stock_actions) · roic.ai MCP (get_profitability_ratios) ·.mcp/fin.py FIS
Knowledge base applied: pattern-net-margin-above-operating-margin-is-a-tripwire ·
pitfall-unrealized-equity-marks-break-headline-pe ·
pitfall-divested-segment-corrupts-multiyear-cagr ·
pitfall-vendor-forward-eps-is-the-wrong-fiscal-year ·
pitfall-dyt-inverts-when-price-caused-the-yield ·
pitfall-yahoo-insider-purchases-counts-rsu-grants ·
pitfall-gate-cleared-by-adjective-not-arithmetic ·
Themes/fintech-payments-infrastructure